Chen W - Search Results

1

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial.

Zhou H, Wang Y, Chen J, He A, Jin J, Lu Q, Zhao Y, Li J, Hou M, Su L, Lai X, Wang W, Liu L, Ma Y, Gao D, Lai W, Zhou X, Jing H, Zhang J, Yang W, Ran X, Lin C, Hao J, Xiao T, Huang Z, Zhu Z, Wang Q, Fang B, Wang B, Song Y, Cai Z, Liu B, Zhu Y, Yang X, Kang X, Li J, Chen W. Zhou H, et al. Among authors: chen j, chen w. Ann Hematol. 2024 Mar;103(3):855-868. doi: 10.1007/s00277-023-05558-y. Epub 2023 Dec 19. Ann Hematol. 2024. PMID: 38112795 Free PMC article.

2

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients.

Jian Y, Chen X, Zhou H, Zhu W, Liu N, Geng C, Chen W. Jian Y, et al. Among authors: chen w, chen x. Medicine (Baltimore). 2016 May;95(19):e3521. doi: 10.1097/MD.0000000000003521. Medicine (Baltimore). 2016. PMID: 27175647 Free PMC article.

3

Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma.

Zhou H, Jian Y, Leng Y, Liu N, Tian Y, Wang G, Gao W, Yang G, Chen W. Zhou H, et al. Among authors: chen w. Int J Hematol. 2017 Mar;105(3):318-325. doi: 10.1007/s12185-016-2139-3. Epub 2016 Nov 15. Int J Hematol. 2017. PMID: 27848179

4

Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study.

Leng Y, Hou J, Jin J, Zhang M, Ke X, Jiang B, Pan L, Yang L, Zhou F, Wang J, Wang Z, Liu L, Li W, Shen Z, Qiu L, Chang N, Li J, Liu J, Pang H, Meng H, Wei P, Jiang H, Liu Y, Zheng X, Yang S, Chen W. Leng Y, et al. Among authors: chen w. Cancer Chemother Pharmacol. 2017 Jun;79(6):1141-1149. doi: 10.1007/s00280-017-3310-0. Epub 2017 May 12. Cancer Chemother Pharmacol. 2017. PMID: 28500554 Clinical Trial.

5

Arsenic trioxide potentiates sensitivity of multiple myeloma cells to lenalidomide by upregulating cereblon expression levels.

Jian Y, Gao W, Geng C, Zhou H, Leng Y, Li Y, Chen W. Jian Y, et al. Among authors: chen w. Oncol Lett. 2017 Sep;14(3):3243-3248. doi: 10.3892/ol.2017.6502. Epub 2017 Jun 30. Oncol Lett. 2017. PMID: 28927072 Free PMC article.

6

Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation.

Gao W, Li J, Jian Y, Yang G, Wu Y, Li Y, Len Y, Liu A, Tian Y, Wang H, Zhou H, Zhang Z, Chen W. Gao W, et al. Among authors: chen w. Int J Hematol. 2019 Feb;109(2):169-174. doi: 10.1007/s12185-018-2547-7. Epub 2018 Oct 11. Int J Hematol. 2019. PMID: 30311142

7

Immunoparesis recovery 1 year after ASCT is independently associated with favorable survival in patients with symptomatic multiple myeloma who undergo autologous stem cell transplantation.

Gao W, Li J, Wu Y, Li Y, Leng Y, Liu A, Yang G, Tian Y, Wang H, Wang G, Wu Z, Ren Z, Chen W. Gao W, et al. Among authors: chen w. Ann Hematol. 2019 May;98(5):1177-1184. doi: 10.1007/s00277-018-3574-4. Epub 2019 Jan 4. Ann Hematol. 2019. PMID: 30610278 Clinical Trial.

8

1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.

Li X, Chen W, Wu Y, Li J, Chen L, Fang B, Feng Y, Liu J, Chen M, Gu J, Huang B, Li J. Li X, et al. Among authors: chen l, chen m, chen w. Oncologist. 2019 Nov;24(11):e1132-e1140. doi: 10.1634/theoncologist.2019-0132. Epub 2019 Aug 27. Oncologist. 2019. PMID: 31455749 Free PMC article.

9

Genome-wide discovery and characterization of long noncoding RNAs in patients with multiple myeloma.

Lu M, Hu Y, Wu Y, Zhou H, Jian Y, Tian Y, Chen W. Lu M, et al. Among authors: chen w. BMC Med Genomics. 2019 Oct 16;12(1):135. doi: 10.1186/s12920-019-0577-5. BMC Med Genomics. 2019. PMID: 31619233 Free PMC article.

10

Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.

Du J, Lu J, Gao W, Liu J, He H, Li L, Li R, Zhou L, Jiang H, Chen W, Fu W, Hou J. Du J, et al. Among authors: chen w. Ann Hematol. 2020 Aug;99(8):1779-1791. doi: 10.1007/s00277-020-04162-8. Epub 2020 Jun 27. Ann Hematol. 2020. PMID: 32594218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61,202 results

Search Page